Presentation Information
[S1-01]Regulatory perspectives for preparing for the next pandemic
SHIOKAWA Tomonori (1. Pharmaceuticals and Medical Devices Agency (PMDA) (Japan))
Keywords:
Pharmaceutical regulation,Vaccines
Login required to view
Comment
To browse or post comments, you must log in.Log in
